Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET

Company Participants

Priyam Shah - Head of IR

Brian McKelligon - CEO

Joseph Driscoll - CFO

Conference Call Participants

Neil Vibhakar - Morgan Stanley

Kyle Mikson - Canaccord Genuity

Mark Massaro - BTIG

David Westenberg - Piper Sandler

Operator

Thank you for standing by, and welcome to the Akoya Biosciences Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions].

And now I'd like to introduce your host for today's program, Priyam Shah, Head of Investor Relations. Please go ahead.

Priyam Shah

Thank you, operator, and thank you everyone who is joining us today on this call. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences. On the call today, we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer. Earlier today, Akoya released financial results for the second quarter ended June 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya's business, please refer to the Risk Factors section of our Form 10-K filed with the Securities and Exchange Commission on March 15, 2022

We urge you to consider these factors and you should be aware that these statements should be considered estimates only and are not a guarantee of future performance. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 8, 2022. Akoya disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.

Lastly, Akoya will be participating in the UBS Genomics 2.0 and the Canaccord Growth Conference this week, and we hope to see many of you in person, either in Dana Point or Boston.